|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.38 USD | -0.29% |
|
+0.21% | -8.80% |
| 04-16 | Helus Pharma Appoints Dr. Ken Kramer as Senior Vice President, Medical Affairs, Effective April 16, 2026 | CI |
| 04-15 | Johnson & Johnson Reported Above-Peer Topline Growth in Q1, BofA Says | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Innovative Medicines and Therapies | 56.2B | 58.05B | 54.32B | 56.33B | 61.16B | |||||
Total Assets | 147B | 139B | 135B | 135B | 134B | |||||
Interest Expense | -2.42B | -2.23B | -2.22B | -2.81B | -2.89B | |||||
Income Tax Expense | 1.44B | 1.63B | 1.38B | -570M | 2.36B | |||||
CAPEX | -787M | -695M | -777M | -974M | -1.21B | |||||
EBT | 12.99B | 13.48B | 6.25B | 3.72B | 6.6B | |||||
D&A | 8.52B | 8.47B | 8.7B | 8.39B | 8.14B | |||||
Operating Income | 17.92B | 18.12B | 12.76B | 9.14B | 15.08B | |||||
Net Income | 11.54B | 11.84B | 4.86B | 4.28B | 4.23B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 43.51B | 45.71B | 41.88B | 43.03B | 46.6B | |||||
Total Assets | - | - | - | 3.33B | 3.4B | |||||
ALL Other Countries | 4.76B | 4.84B | 5.04B | 5.45B | 5.76B | |||||
Total Assets | 341M | 323M | 417M | 318M | 420M | |||||
Total Assets | 3.37B | 3.24B | 3.14B | - | - | |||||
Total Assets | 1.4B | 1.37B | 1.43B | 1.48B | 1.8B | |||||
Germany | 1.22B | 1.34B | 1.27B | 1.46B | 1.74B | |||||
Japan | 1.09B | 956M | 1.01B | 1.12B | 1.27B | |||||
Canada | 1.4B | 1.16B | 1.08B | 1.09B | 1.22B | |||||
China | 857M | 912M | 950M | 917M | 1.01B | |||||
France | 936M | 787M | 780M | 776M | 806M | |||||
United Kingdom | 497M | 462M | 417M | 522M | 626M | |||||
Spain | 519M | 506M | 501M | 528M | 609M | |||||
Italy | 506M | 444M | 484M | 511M | 580M | |||||
Brazil | 368M | 430M | 439M | 464M | 478M | |||||
Australia | 533M | 508M | 472M | 463M | 459M | |||||
The Netherlands | - | - | - | - | - |
- Stock Market
- Equities
- ABBV Stock
- Financials AbbVie Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition